Skip to content

Talking Medication Safety in Specialty Pharmacy with ISMP | NASP Specialty Pharmacy Podcast

Pharmacy Podcast Network

28m
Transcript

Original podcast

Summary

Written by a model from the transcript; not yet reviewed.

This episode explores medication safety in specialty pharmacy through a discussion between host Sheila Arkat and guest Dr. Rita Jew, President of the Institute for Safe Medication Practices (ISMP). Dr. Jew details how specialty pharmacy presents high-risk challenges due to complex drug therapies, narrow therapeutic indices, self-injection requirements at home, and intricate delivery workflows. The conversation examines common shipping errors, the dangers of benchmarking low medication error rates, and the tools ISMP offers, including proactive risk assessments and safety self-assessments. Listeners learn actionable strategies for building resilient systems and cultivating a strong safety culture.

  • Avoid using low medication error rates as a performance metric because it discourages reporting and hides systemic risks. 12:20
  • Confirm patient addresses early in the onboarding process and separate outdated delivery details to prevent shipping errors. 16:54
  • Use multi-role self-assessments involving administrators, pharmacists, and technicians to uncover gaps between official policy and actual pharmacy practice. 24:33

Chapters

  1. 0:05
    Podcast Introduction and Host Overview

    Hosts introduce the NASP Specialty Pharmacy Podcast and set the context for the episode.

  2. 1:29
    Introduction of Dr. Rita Jew and ISMP

    Sheila Arkat welcomes Dr. Rita Jew and explains her role at ISMP.

  3. 3:05
    What Is ISMP and Its Mission

    Dr. Jew outlines ISMP’s purpose, history, and focus on medication safety.

  4. 6:08
    Importance of Medication Safety in Specialty Pharmacy

    Discussion of why specialty pharmacies face higher risks and the need for robust safety systems.

  5. 8:30
    Patient Complexity and Environmental Factors

    Explores how patient vulnerability and delivery conditions affect safety.

  6. 10:16
    Common Medication Safety Challenges in Specialty Pharmacy

    Identifies typical risks such as communication breakdowns, workflow interruptions, and technology issues.

  7. 14:10
    Shipping and Delivery Errors and Prevention Strategies

    Examines the prevalence of shipping errors and offers practical solutions to mitigate them.

  8. 21:49
    ISMP Resources for Risk Assessment and Improvement

    Details ISMP’s proactive risk assessments, self-assessments, and best practice tools for pharmacies.

  9. 27:18
    Key Takeaway: Systemic Weaknesses Drive Errors

    Emphasizes that most medication errors stem from system flaws rather than individual mistakes.

  10. 27:59
    Episode Closing and Call to Action

    Hosts thank the guest, provide membership information, and sign off.

Highlights

  • 3:10

    ISMP Mission and Focusinsight

    Dr. Rita Jew explains that ISMP is an independent nonprofit organization devoted entirely to medication safety, analyzing error reports and creating practical strategies to prevent patient harm.

  • 6:35

    Specialty Medication Risksinsight

    Specialty drugs involve high complexity, narrow therapeutic indexes, and complex dosing, which require specialized handling, onboarding, and ongoing patient monitoring.

  • 12:20

    Flaw in Error Ratesdebate

    Dr. Jew warns against benchmarking low medication error rates, arguing that if organizations want zero errors, they just need to tell people to stop reporting.

  • 14:30

    Shipping and Delivery Errorsdata

    A specialty pharmacy reported that shipping and delivery errors account for nearly half of their internally reported errors, ranging from wrong addresses to delayed therapies.

  • 20:08

    The Cold Chain Comparisonstory

    Dr. Jew shares an anecdote about receiving commercial shipments of fish with embedded RFID tracking and temperature controls, arguing specialty drugs deserve similar logistical rigor.

  • 22:39

    Proactive Risk Assessmentsstrategy

    ISMP provides a library of proactive risk assessments for over 350 drugs and biosimilars to help specialty pharmacies evaluate new FDA-approved medications efficiently.

Quotes

  • “Our mission is very simple, but powerful. It is advancing patient safety worldwide by empowering the healthcare community to prevent medication errors.”
    Unnamed speaker · 3:31
  • “We are founded and rooted in medication error reporting. For more than 30 years, ISMP, through our medication error reporting program, has identified medication use risk.”
    Unnamed speaker · 3:45
  • “Most medication errors stem from system weaknesses and not individual failures.”
    Unnamed speaker · 27:27
  • “Shipping and delivery errors are very common. As a matter of fact, we are working, currently working on an article in our ambulatory and community newsletter.”
    Unnamed speaker · 14:17

About this episode

In this episode, Sheila Arquette, President & CEO of NASP, speaks with Rita Jew, PharmD, MBA, President of the Institute for Safe Medication Practices (ISMP), about what it takes to keep specialty medication use safe. They discuss the distinct risks of specialty medications and detail ISMP's mission to prevent medication errors, providing drug-specific risk assessments, resources, and interactive tools that help pharmacies uncover gaps between policy and practice.

Transcript

0:00
28:46

4,060 words · 4 speakers

Topics

  • Institute for Safe Medication Practices
  • Pharmacy Podcast Network
  • Medication Safety Proactive Risk Assessment
  • Medication Safety Membership
  • National Association of Specialty Pharmacy
  • ACRI
  • UCSF Health
  • CHOC Children's
  • Children's Hospital of Philadelphia
  • University of California, San Francisco

Page updated · transcript and summary are machine-generated